ACLARION, INC. Cash
ACLARION, INC. (ACON) had Cash of $602.72 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:Cash · last filed 2026-08-06
- 2026-06-30: Cash $602.72K.
- 2026-03-31: Cash $279.57K.
- 2025-12-31: Cash $273.29K.
- 2025-09-30: Cash $307.11K.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2026-06-30 | $602.72K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $279.57K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $273.29K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $307.11K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $900.75K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $14.76M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $463.66K 10-K · filed 2026-03-18 | $460.00K 10-K · filed 2025-04-09 |
| 2023-12-31 | $1.00M 10-K · filed 2024-03-28 | |
| 2023-09-30 | $161.45K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $604.52K 10-Q · filed 2023-08-25 | |
| 2023-03-31 | $447.98K 10-Q · filed 2023-07-03 | |
| 2022-12-31 | $1.47M 10-Q · filed 2023-11-14 | |
| 2022-09-30 | $2.66M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $3.79M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $50.45K 10-Q · filed 2022-06-06 | |
| 2021-12-31 | $432.53K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |